Diclomezin

CAS : 62865-36-5

Ref. 3D-MCA86536

Informations sur le produit

• Nom: Diclomezin
• Synonymes: 3(2H)-Pyridazinone, 6-(3,5-dichloro-4-methylphenyl)-, 6-(3,5-dichloro-4-methylphenyl)-3(2H)-pyridazinone, 6-(3,5-dichloro-4-methylphenyl)pyridazin-3(2H)-one, Monguard

Description

Diclomezin is a medicinal analog that has been shown to inhibit the activity of tumor kinases in human cancer cells. It acts as an inhibitor of protein kinases, leading to apoptosis or programmed cell death in cancer cells. Diclomezin has been found to be effective against various types of cancers, including lung and breast cancers. This anticancer drug has also been shown to have a favorable safety profile, with no significant side effects reported in clinical trials. Diclomezin is excreted through urine and has been extensively studied as a potential therapeutic agent for cancer treatment. This inhibitor may have promising applications in the development of novel therapies for Chinese patients suffering from cancer.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 255.1 g/mol
• Formule: C₁₁H₈Cl₂N₂O
• Degré de pureté: Min. 95%